Validation of a meta-analysis

The effects of fish oil in rheumatoid arthritis

Paul R. Fortin, Robert A. Lew, Matthew H. Liang, Elizabeth A. Wright, Laurel A Beckett, Thomas C. Chalmers, Richard I. Sperling

Research output: Contribution to journalArticle

167 Citations (Scopus)

Abstract

The purpose of this study was to validate the results of a meta-analysis showing the efficacy of fish oil in rheumatoid arthritis with the results of a re-analysis of the complete primary data set. A Medline search yielded seven published papers. Three additional trials were found by contacting authorities in the field. Inclusion criteria included (1) a double-blind, placebo-controlled study, (2) use of at least one of seven predetermined outcome measures, (3) results reported for both placebo and treatment groups at baseline and follow-up, (4) randomization, and (5) parallel or cross-over design. Papers were scored for quality. Demographic and outcomes variables were collected. For the re-analysis of the primary data, the same variables were abstracted for the 395 individual patients randomized. The meta-analysis demonstrated that dietary fish oil supplementation for 3 months significantly reduced tender joint count (rate difference [RD][95% CI]= -2.9 [-3.8 to -2.1][p = 0.001]) and morning stiffness (RD [95% CI] = -25.9 [-44.3 to -7.5][p < 0.01]) as compared with heterogeneous dietary control oils. The re-analysis of the primary data confirmed a significant reduction in tender joint count (p = 0.001) and in morning stiffness (p < 0.02) in the parallel analysis that ignored interaction terms. The analyses that included an interaction term between site and treatment again confirmed a significant reduction in tender joint count. The results for morning stiffness were similar to the meta-analysis, but did not quite reach statistical significance (p = 0.052-0.083). The relative improvements in the other outcome variables did not reach statistical significance. Use of fish oil improved the number of tender joints and duration of morning stiffness at 3 months as analyzed by both meta- and mega-analysis. The fuller mega-analysis confirmed the results of the meta-analysis. The advantages of mega-analysis were as follows: (1) the ability to analyze the homogeneity of the patient populations, (2) the ability to make clinically sensible adjustments in the form of the comparison, and (3) the ability to examine subsets of the data.

Original languageEnglish (US)
Pages (from-to)1379-1390
Number of pages12
JournalJournal of Clinical Epidemiology
Volume48
Issue number11
DOIs
StatePublished - 1995
Externally publishedYes

Fingerprint

Fish Oils
Meta-Analysis
Rheumatoid Arthritis
Joints
Unsaturated Dietary Fats
Placebos
Random Allocation
Cross-Over Studies
Demography
Outcome Assessment (Health Care)
Therapeutics
Population

Keywords

  • Eicosapentaenoic acid Rheumatoid arthritis
  • Fish oil
  • Mega-analysis
  • Meta-analysis
  • Technology assessment

ASJC Scopus subject areas

  • Epidemiology
  • Medicine(all)
  • Public Health, Environmental and Occupational Health

Cite this

Fortin, P. R., Lew, R. A., Liang, M. H., Wright, E. A., Beckett, L. A., Chalmers, T. C., & Sperling, R. I. (1995). Validation of a meta-analysis: The effects of fish oil in rheumatoid arthritis. Journal of Clinical Epidemiology, 48(11), 1379-1390. https://doi.org/10.1016/0895-4356(95)00028-3

Validation of a meta-analysis : The effects of fish oil in rheumatoid arthritis. / Fortin, Paul R.; Lew, Robert A.; Liang, Matthew H.; Wright, Elizabeth A.; Beckett, Laurel A; Chalmers, Thomas C.; Sperling, Richard I.

In: Journal of Clinical Epidemiology, Vol. 48, No. 11, 1995, p. 1379-1390.

Research output: Contribution to journalArticle

Fortin, PR, Lew, RA, Liang, MH, Wright, EA, Beckett, LA, Chalmers, TC & Sperling, RI 1995, 'Validation of a meta-analysis: The effects of fish oil in rheumatoid arthritis', Journal of Clinical Epidemiology, vol. 48, no. 11, pp. 1379-1390. https://doi.org/10.1016/0895-4356(95)00028-3
Fortin, Paul R. ; Lew, Robert A. ; Liang, Matthew H. ; Wright, Elizabeth A. ; Beckett, Laurel A ; Chalmers, Thomas C. ; Sperling, Richard I. / Validation of a meta-analysis : The effects of fish oil in rheumatoid arthritis. In: Journal of Clinical Epidemiology. 1995 ; Vol. 48, No. 11. pp. 1379-1390.
@article{f5a8ffc2741847c39af28c43d96f1928,
title = "Validation of a meta-analysis: The effects of fish oil in rheumatoid arthritis",
abstract = "The purpose of this study was to validate the results of a meta-analysis showing the efficacy of fish oil in rheumatoid arthritis with the results of a re-analysis of the complete primary data set. A Medline search yielded seven published papers. Three additional trials were found by contacting authorities in the field. Inclusion criteria included (1) a double-blind, placebo-controlled study, (2) use of at least one of seven predetermined outcome measures, (3) results reported for both placebo and treatment groups at baseline and follow-up, (4) randomization, and (5) parallel or cross-over design. Papers were scored for quality. Demographic and outcomes variables were collected. For the re-analysis of the primary data, the same variables were abstracted for the 395 individual patients randomized. The meta-analysis demonstrated that dietary fish oil supplementation for 3 months significantly reduced tender joint count (rate difference [RD][95{\%} CI]= -2.9 [-3.8 to -2.1][p = 0.001]) and morning stiffness (RD [95{\%} CI] = -25.9 [-44.3 to -7.5][p < 0.01]) as compared with heterogeneous dietary control oils. The re-analysis of the primary data confirmed a significant reduction in tender joint count (p = 0.001) and in morning stiffness (p < 0.02) in the parallel analysis that ignored interaction terms. The analyses that included an interaction term between site and treatment again confirmed a significant reduction in tender joint count. The results for morning stiffness were similar to the meta-analysis, but did not quite reach statistical significance (p = 0.052-0.083). The relative improvements in the other outcome variables did not reach statistical significance. Use of fish oil improved the number of tender joints and duration of morning stiffness at 3 months as analyzed by both meta- and mega-analysis. The fuller mega-analysis confirmed the results of the meta-analysis. The advantages of mega-analysis were as follows: (1) the ability to analyze the homogeneity of the patient populations, (2) the ability to make clinically sensible adjustments in the form of the comparison, and (3) the ability to examine subsets of the data.",
keywords = "Eicosapentaenoic acid Rheumatoid arthritis, Fish oil, Mega-analysis, Meta-analysis, Technology assessment",
author = "Fortin, {Paul R.} and Lew, {Robert A.} and Liang, {Matthew H.} and Wright, {Elizabeth A.} and Beckett, {Laurel A} and Chalmers, {Thomas C.} and Sperling, {Richard I.}",
year = "1995",
doi = "10.1016/0895-4356(95)00028-3",
language = "English (US)",
volume = "48",
pages = "1379--1390",
journal = "Journal of Clinical Epidemiology",
issn = "0895-4356",
publisher = "Elsevier USA",
number = "11",

}

TY - JOUR

T1 - Validation of a meta-analysis

T2 - The effects of fish oil in rheumatoid arthritis

AU - Fortin, Paul R.

AU - Lew, Robert A.

AU - Liang, Matthew H.

AU - Wright, Elizabeth A.

AU - Beckett, Laurel A

AU - Chalmers, Thomas C.

AU - Sperling, Richard I.

PY - 1995

Y1 - 1995

N2 - The purpose of this study was to validate the results of a meta-analysis showing the efficacy of fish oil in rheumatoid arthritis with the results of a re-analysis of the complete primary data set. A Medline search yielded seven published papers. Three additional trials were found by contacting authorities in the field. Inclusion criteria included (1) a double-blind, placebo-controlled study, (2) use of at least one of seven predetermined outcome measures, (3) results reported for both placebo and treatment groups at baseline and follow-up, (4) randomization, and (5) parallel or cross-over design. Papers were scored for quality. Demographic and outcomes variables were collected. For the re-analysis of the primary data, the same variables were abstracted for the 395 individual patients randomized. The meta-analysis demonstrated that dietary fish oil supplementation for 3 months significantly reduced tender joint count (rate difference [RD][95% CI]= -2.9 [-3.8 to -2.1][p = 0.001]) and morning stiffness (RD [95% CI] = -25.9 [-44.3 to -7.5][p < 0.01]) as compared with heterogeneous dietary control oils. The re-analysis of the primary data confirmed a significant reduction in tender joint count (p = 0.001) and in morning stiffness (p < 0.02) in the parallel analysis that ignored interaction terms. The analyses that included an interaction term between site and treatment again confirmed a significant reduction in tender joint count. The results for morning stiffness were similar to the meta-analysis, but did not quite reach statistical significance (p = 0.052-0.083). The relative improvements in the other outcome variables did not reach statistical significance. Use of fish oil improved the number of tender joints and duration of morning stiffness at 3 months as analyzed by both meta- and mega-analysis. The fuller mega-analysis confirmed the results of the meta-analysis. The advantages of mega-analysis were as follows: (1) the ability to analyze the homogeneity of the patient populations, (2) the ability to make clinically sensible adjustments in the form of the comparison, and (3) the ability to examine subsets of the data.

AB - The purpose of this study was to validate the results of a meta-analysis showing the efficacy of fish oil in rheumatoid arthritis with the results of a re-analysis of the complete primary data set. A Medline search yielded seven published papers. Three additional trials were found by contacting authorities in the field. Inclusion criteria included (1) a double-blind, placebo-controlled study, (2) use of at least one of seven predetermined outcome measures, (3) results reported for both placebo and treatment groups at baseline and follow-up, (4) randomization, and (5) parallel or cross-over design. Papers were scored for quality. Demographic and outcomes variables were collected. For the re-analysis of the primary data, the same variables were abstracted for the 395 individual patients randomized. The meta-analysis demonstrated that dietary fish oil supplementation for 3 months significantly reduced tender joint count (rate difference [RD][95% CI]= -2.9 [-3.8 to -2.1][p = 0.001]) and morning stiffness (RD [95% CI] = -25.9 [-44.3 to -7.5][p < 0.01]) as compared with heterogeneous dietary control oils. The re-analysis of the primary data confirmed a significant reduction in tender joint count (p = 0.001) and in morning stiffness (p < 0.02) in the parallel analysis that ignored interaction terms. The analyses that included an interaction term between site and treatment again confirmed a significant reduction in tender joint count. The results for morning stiffness were similar to the meta-analysis, but did not quite reach statistical significance (p = 0.052-0.083). The relative improvements in the other outcome variables did not reach statistical significance. Use of fish oil improved the number of tender joints and duration of morning stiffness at 3 months as analyzed by both meta- and mega-analysis. The fuller mega-analysis confirmed the results of the meta-analysis. The advantages of mega-analysis were as follows: (1) the ability to analyze the homogeneity of the patient populations, (2) the ability to make clinically sensible adjustments in the form of the comparison, and (3) the ability to examine subsets of the data.

KW - Eicosapentaenoic acid Rheumatoid arthritis

KW - Fish oil

KW - Mega-analysis

KW - Meta-analysis

KW - Technology assessment

UR - http://www.scopus.com/inward/record.url?scp=0028818261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028818261&partnerID=8YFLogxK

U2 - 10.1016/0895-4356(95)00028-3

DO - 10.1016/0895-4356(95)00028-3

M3 - Article

VL - 48

SP - 1379

EP - 1390

JO - Journal of Clinical Epidemiology

JF - Journal of Clinical Epidemiology

SN - 0895-4356

IS - 11

ER -